Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zunino

Showing results (71-80 of 204) with videos related to

Pageof 21
Sort By:
Anticancer Research|March 1, 1989
Malignant transformation of host cells by a human small cell lung cancer xenografted into nude miceC Soranzo, A Ingrosso, G Pratesi, et al.
Cancer Research|May 1, 1997
Irreversible and reversible topoisomerase II DNA cleavage stimulated by clerocidin: sequence specificity and structural drug determinantsM Binaschi, G Zagotto, M Palumbo, et al.
Current Cancer Drug Targets|February 7, 2003
Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repairS Manic, L Gatti, N Carenini, et al.
Cancer Research|June 1, 1976
Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivativesA Di Marco, A M Casazza, R Gambetta, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancerF Di Re, S Bohm, S Oriana, et al.
Oncogene|August 9, 2001
Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cellsB Del Bello, M A Valentini, F Zunino, et al.
Journal of Molecular Recognition : JMR|September 1, 1994
Conformational properties of topoisomerase II inhibitors and sequence specificity of DNA cleavageM Palumbo, M Mabilia, A Pozzan, et al.
Chemico-Biological Interactions|January 1, 1989
Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drugF Zunino, G Pratesi, A Micheloni, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and ratsF Villani, C Manzotti, M Mella, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 7, 1999
Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selectionS C Righetti, P Perego, E Corna, et al.
Pageof 21

Showing results (71-80 of 204) with videos related to

Sort By:
Pageof 21
Anticancer Research|March 1, 1989
Malignant transformation of host cells by a human small cell lung cancer xenografted into nude miceC Soranzo, A Ingrosso, G Pratesi, et al.
Cancer Research|May 1, 1997
Irreversible and reversible topoisomerase II DNA cleavage stimulated by clerocidin: sequence specificity and structural drug determinantsM Binaschi, G Zagotto, M Palumbo, et al.
Current Cancer Drug Targets|February 7, 2003
Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repairS Manic, L Gatti, N Carenini, et al.
Cancer Research|June 1, 1976
Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivativesA Di Marco, A M Casazza, R Gambetta, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancerF Di Re, S Bohm, S Oriana, et al.
Oncogene|August 9, 2001
Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cellsB Del Bello, M A Valentini, F Zunino, et al.
Journal of Molecular Recognition : JMR|September 1, 1994
Conformational properties of topoisomerase II inhibitors and sequence specificity of DNA cleavageM Palumbo, M Mabilia, A Pozzan, et al.
Chemico-Biological Interactions|January 1, 1989
Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drugF Zunino, G Pratesi, A Micheloni, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and ratsF Villani, C Manzotti, M Mella, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 7, 1999
Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selectionS C Righetti, P Perego, E Corna, et al.
Pageof 21